Uploaded January 2024 | Updated September 2026, 3 hours ago
In this episode of the Brainstorm Podcast, I was joined by Dr. Amy Rochford, a groundbreaking figure in the field of biohybrid neural interfaces. Dr. Rochford, with an impressive academic background from Cardiff University, University College London, the University of Cambridge, and Science Corp, brings her expertise in combining human stem cells with traditional electrical neural interfaces. Currently a key member of the technical team at Science Corporation, she shares her journey from academia to industry, focusing on neurotechnology's potential to transform treatments for brain and nervous system injuries.
Dr. Rochford provides an in-depth look at her pioneering work in biohybrid interfaces, explaining how these systems bridge biological and artificial components for improved communication pathways between the nervous system and external devices. Her discussion covers the challenges and breakthroughs in developing these interfaces, particularly their application in peripheral nerve injuries. The episode also delves into her current projects at Science Corporation, including the development of retinal visual prostheses and the exciting prospects of biohybrid technologies in clinical applications. For anyone fascinated by the intersection of biology, technology, and neuroengineering, this episode offers a glimpse into the future of biohybrid neural interfaces and their potential to revolutionize medical treatments.
Links:
Dr. Amy Rochford's LinkedIn: linkedin.com/in/amy-rochford-04946877
Twitter: twitter.com/rochford_amy?lang=en
Science Corporation's Website: https://science.xyz/
Dr. Rochford's Papers: scholar.google.com/citations?user=rUbLqYkAAAAJ&hl=en
#brainstream #podcast #neuroscience
In this episode of the Brainstorm Podcast, I was joined by Dr. Amy Rochford, a groundbreaking figure in the field of biohybrid neural interfaces. Dr. Rochford, with an impressive academic background from Cardiff University, University College London, the University of Cambridge, and Science Corp, brings her expertise in combining human stem cells with traditional electrical neural interfaces. Currently a key member of the technical team at Science Corporation, she shares her journey from academia to industry, focusing on neurotechnology's potential to transform treatments for brain and nervous system injuries.
Dr. Rochford provides an in-depth look at her pioneering work in biohybrid interfaces, explaining how these systems bridge biological and artificial components for improved communication pathways between the nervous system and external devices. Her discussion covers the challenges and breakthroughs in developing these interfaces, particularly their application in peripheral nerve injuries. The episode also delves into her current projects at Science Corporation, including the development of retinal visual prostheses and the exciting prospects of biohybrid technologies in clinical applications. For anyone fascinated by the intersection of biology, technology, and neuroengineering, this episode offers a glimpse into the future of biohybrid neural interfaces and their potential to revolutionize medical treatments.
Links:
Dr. Amy Rochford's LinkedIn: linkedin.com/in/amy-rochford-04946877
Twitter: twitter.com/rochford_amy?lang=en
Science Corporation's Website: https://science.xyz/
Dr. Rochford's Papers: scholar.google.com/citations?user=rUbLqYkAAAAJ&hl=en
#brainstream #podcast #neuroscience
